CSIR's NMITLI Programme Takes Rs. 100-crore Hit in Failed Industry Projects
Over one-third of funds distributed under an innovative public-private R&D initiative in the country may not come back to the public exchequer as the private firms that taken these soft loans have defaulted on payment as the projects failed to produce tangible results, the Lok Sabha was informed recently.
The Council of Scientific and Industrial Research (CSIR) disbursed a total of Rs. 298-crore under its New Millennium Indian Technology Leadership Initiative (NMITLI) to 45 different projects since the inception of the scheme in early 2000s, but many firms failed to pay back the soft loan given at an interest rate of 3 per cent, leading to a loss of Rs. 102-crore, Union Science and Technology Minister Dr. Harsh Vardhan said in a reply to a question.
One of the major defaulters was Ghaziabad-based Samtel Color, which was given NMITLI funds worth Rs. 20.63 crore for developing next-generation plasma display technology indigenously in 2006-07. The company became sick after availing of the loan and beginning to implement the project, Dr. Vardhan said.
There have been several successfully completed projects too under the scheme, which were also handled by many marquee firms like TCS, Cadila Pharma, Lupin and Biocon, among others. However, what the Minister did not elaborate was that whether any steps have been taken for loan recovery. Technology development projects all over the world are considered inherently risky and the losses are often offset by successful projects.
Looking for chemical products? Let suppliers reach out to you!
2026-07-06
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The price of Merck’s COVID-19 specific drug is 40 times the cost; Fosun Pharma sells its diagnostic segment for nearly 1.6 billion yuan
-
The opening of Green Building Expo in Zhengzhou
-
The second full-scale landing in the year is expected to stabilize
-
Technical Strength of Special Functional Coatings
-
Huide Technology Partners with U.S. Firm to Open the Door to Mass Production of Circular TPU
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
Kemira Acquires AquaBlue
-
Sulzer Launches Polystyrene Recycling Technology
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
Recommend Reading
-
SIBUR Develops New Polypropylene for Retort Packaging
-
Polyvantis Opens Shanghai Technical Center
-
TDI Supply Tightens and Prices Surge: Can Cangzhou Dahua Reap the "Chemical Dividend"?
-
OIL and IREL Sign MoU to Collaborate on Rare Earths and Critical Minerals
-
Kemira to Expand Drinking Water Treatment Portfolio with New ACH Production Line
-
June China Urea Market Fluctuates
-
Demand Side Enters at Lower Levels; ABS Rallies from Low Levels by End of December
-
The FDA Officially Blesses AI for Liver Drug Development
-
October Activated Carbon Prices Decline
-
In June, the Chinese acetone market plummeted significantly